Strengthening the supportive environment and scaling up prevention, treatment and care to contain HIV epidemic in Tajikistan
What is the Programme about?
As of January 2018 Tajikistan remains in the concentrated stage HIV epidemic spread mostly among key population group The trend of HIV was on the rise, with Tajikistan being one of the few countries in which HIV prevalence increased by more than 25% in the past 10 years. As of the end of December 2016, it was estimated that 16,321 people in Tajikistan were living with HIV, according to the date provided by the Ministry of health in Tajikistan. As of December 2017 total 9,957 people (66.6% M; 33.4% F) have been diagnosed with HIV. Among this total, 2,405 have died since the beginning of epidemic. Currently Tajikistan is in the process of finalization of the revised national HIV treatment protocols to align with latest WHO recommendations to “test and treat” people living with HIV, including children, adolescents, adults, pregnant and breastfeeding women, and people with co-infections.
The UNDP Country Programme Document for the period of 2016-2020 and the UNDAF 2016-2020 objectives are consistent with national strategy papers, namely the National Health Strategy 2011-2020. Similarly, the overall goal of the project is directly linked to and harmonized with four main objectives of the National Programme on HIV/AIDS for 2017-2020 and the National Health Strategy 2011-2020: i) improving the nation’s reproductive potential: women’s, maternal, and new-born health; ii) healthy childhood; iii) prevention and control of high-impact infections; and iv) a fulfilling life with non-infectious and chronic diseases - that promotes creating a healthier living environment and improving health of the population, particularly key-affected population groups. The NHS aims at strengthened performance of the health care sector which will manifest itself in a reduced disease burden (socio-economic loss from premature death and disability) on the economy and the society of Tajikistan.
The HIV project activities for 2018-2020 comprised of 10 modules (objectives) focusing on HIV prevention and harm reduction among key populations, including prison inmates; treatment, care and support for PLWH; tuberculosis prevention and treatment among PLWH; prevention of mother-to-child HIV transmission; elimination of legal barriers in HIV area; improving the system of monitoring and evaluation through enhancing healthcare information system in the country
The main goal of the HIV project is to achieve universal access to HIV services as well as prevention, treatment, care and support that enables people to live fulfilling life. The project targets are aligned with the objectives of the UNDP Country Programme Development 2016-2020 alongside with the National Health Strategy 2010-2020.
Furthermore, the project will continue contributing to national health care reform through building and improving technical and capacities of health professionals, promoting participation of civil society in the response to the epidemic, and enhancing the cooperation of NGOs with the public health sector.
Accomplishments so far
- 60% of the estimated number (23,100) of people who inject drugs reached with HIV prevention programs and 29.5% received HIV testing and know their results;
- 72% of the estimated number (14,100) of sex workers reached with HIV prevention programs and 39% received HIV testing and know their results;
- 94% of HIV-positive pregnant women received antiretrovirals to reduce the risk of mother-to-child transmission;
- 54% of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth;
- 48% of the estimated number of MSM (13,400) reached with HIV prevention programs and 6.6% received HIV testing and know their results;
- 95% of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment;
- 5,018 people living with HIV currently receiving antiretroviral therapy as of December 2017;
- 70.5% of adults and children that initiated ART, with an undetectable viral load at 12 months;
Who finances it?
The Global Fund to fight HIV/AIDS, tuberculosis and malaria
Delivery in previous fiscal year